Page last updated: 2024-08-22

platinum and Carcinoma

platinum has been researched along with Carcinoma in 53 studies

Research

Studies (53)

Timeframe	Studies, this research(%)	All Research%
pre-1990	5 (9.43)	18.7374
1990's	18 (33.96)	18.2507
2000's	3 (5.66)	29.6817
2010's	14 (26.42)	24.3611
2020's	13 (24.53)	2.80

Authors

Authors	Studies
Davidson, B; Elstrand, MB	1
Cheong, TF; Chiang, KY; Ho, JCM; Ip, MSM; Kwok, WC; Lam, DCL; Tam, TCC	1
Banda, K; Chandok, H; Dobrolecki, L; Kumar, P; Lewis, MT; Liu, ET; Menghi, F; Radke, MR; Rodriguez, IV; Somlo, G; Straub, R; Swisher, EM; Yost, SE; Yuan, Y	1
Ermini, ML; Gonnelli, A; Mapanao, AK; Menicagli, M; Santi, M; Sarogni, P; Voliani, V; Zamborlin, A	1
Aghajanian, C; Clamp, AR; Coleman, RL; Colombo, N; Dean, A; Fong, PC; Gancedo, MA; Goble, S; Goh, JC; Holloway, RW; Kwan, T; Leary, A; Ledermann, JA; Lin, KK; Lorusso, D; Maloney, L; O'Malley, DM; Oaknin, A; Oza, AM; Scambia, G; Swisher, EM; Weberpals, JI	1
Fu, HC; Huang, YC; Kao, CH; Lan, J; Lin, H; Liu, CT; Ou, YC; Wu, CH	1
Alidra, A; Rambeau, A; Riot, A	1
Li, Z; Liu, XM; Qiao, X; Shi, SH; Xu, JY	1
Barth, MC; Häfner, N; Runnebaum, IB; Weigand, W	1
Buttitta, F; D'Angelo, E; Di Marino, P; Felicioni, L; Ferro, B; Marchetti, A; Pasciuto, MP; Primavera, FC; Rossetti, R; Tudini, M; Zampacorta, C	1
Aghajanian, C; Armstrong, DK; Banerjee, S; Cameron, T; Clamp, AR; Coleman, RL; Colombo, N; Dean, A; Fong, PC; Gancedo, MA; García-Donas, J; Goble, S; Goh, JC; Holloway, RW; Leary, A; Ledermann, JA; Lorusso, D; Maloney, L; O'Malley, DM; Oaknin, A; Oza, AM; Scambia, G; Swisher, EM; Weberpals, JI	1
Adawi, R; Gopas, J; Khamaisi, H; Koren Carmi, Y; Mahajna, J; Mahmoud, H	1
Cavalieri, S; Licitra, L	1
Ebbesson, A; Hartman, L; Hedenfalk, I; Jönsson, JM; Malander, S; Martín de la Fuente, L; Måsbäck, A; Nilbert, M	1
Ambriović-Ristov, A; Arany, I; Brozovic, A; Fiket, Z; Fritz, G; Köberle, B; Majhen, D; Osmak, M; Polančac, DS; Vuković, L	1
Chen, X; Feng, J; Guan, X; Hong, Y; Song, H; Ye, J; You, X; Zheng, P	1
Hasegawa, K; Ichikawa, R; Kato, R; Kawamura, K; Oe, S; Torii, Y; Udagawa, Y	1
Chatterjee, PK; Gupta, M; Kohn, N; Metz, CN; Rosales, I; Solanki, MH; Xue, X; Yeboah, MM	1
Chai, A; Dai, R; Li, H; Zhang, Z	1
Dong, M; Gui, L; He, X; Hu, S; Jia, B; Liu, P; Qin, Y; Yang, J; Yang, S; Zhang, C; Zhou, S	1
Di Palma, M; Guillot, A; Médioni, J; Spaeth, D; Théodore, C	1
Chen, IS; Kirn, D; Lee, JY; Lin, TK; Liu, TC; Tsao, CJ	1
Blank, H; Bräse, S; Brenner, P; Crone, M; Esselen, M; Gehrke, H; Gerthsen, D; Marko, D; Muller, T; Pelka, J; Schneider, R; Send, W; Türk, M; Zibat, V	1
Güth, U; Huang, DJ; Schötzau, A; Wight, E	1
Fernandez, G; Garnier, R; Hasni-Pichard, H; Konate, A; Mezzaroba, D; Pocard, M; Poupon, J; Villa, A	1
Clamp, AR; Evans, S; Griffiths, RW; Hasan, J; Jayson, GC; Kumaran, GC; Mitchell, CL; Welch, RS; Zee, YK	1
Iramaneerat, K; Khemapech, N; Mutirangura, A; Rattanatunyong, P; Triratanachat, S	1
Pavlidis, N	1
Blair, E; Cohen, EE; Golden, DW; Haraf, DJ; Nwizu, T; Rudra, S; Stenson, KM; Vokes, EE; Witt, ME	1
Alvarez, RD; Barnes, MN; Huh, WK; Kilgore, LC; Leath, CA; Partridge, EE; Rocconi, RP; Straughn, JM	1
Hayashi, S; Kano, E; Matsumoto, H; Ohtsubo, T; Saito, H; Saito, T; Sugimoto, C; Tanaka, N	1
Li, M; Liu, J	1
Alimonti, A; Bedini, AV; Canevali, C; Caroli, S; Milani, F; Morazzoni, F; Moschetti, I; Petrucci, F; Ravasi, G; Todeschini, R	1
Gore, ME; Taylor, AE	1
Hoskins, PJ; Swenerton, KD	1
Funakoshi, T; Kojima, S; Shimada, H; Takahashi, K	1
Barakat, RR; Curtin, JP; Hakes, TB; Hoskins, WJ; Rubin, SC; Wong, GY	1
Armstrong, D; Carmichael, J; Gordon, A; Malfetano, J; ten Bokkel Huinink, W	1
Holford, J; Kelland, LR; Rogers, P	1
Chaney, SG; Luo, FR; Wyrick, SD	1
Besmaine, A; Cuvier, C; Cvitkovic, E; Dupont-André, G; Goldwasser, F; Kalla, S; Lokiec, F; Mahjoubi, M; Marty, M; Méry-Mignard, D; Misset, JL; Ouldkaci, M; Wasserman, E	1
Hunakova, L; Kelland, LR; O'Neill, CF	1
Caserini, C; Colangelo, D; Farrell, N; Gatti, L; Leone, R; Perego, P; Spinelli, S; Supino, R; Zunino, F	1
Aggarwal, SK; McAllister, PK; Rosenberg, B; Wagner, RW	1
Klys, HS; Matheson, LM; McKay, K; Smyth, JF; Tothill, P	1
Almadrones, L; Hakes, T; Hoskins, W; Jones, W; Lewis, JL; Markman, M; Pizzuto, F; Reichman, B; Rubin, S	1
Daoud, SS; Forde, NH	1
Cavaletti, G; Minoia, A; Pizzini, G; Tredici, G	1
Chambers, JT; Chambers, SK; Schwartz, PE; Voynick, IM	1
Elferink, F; Gall, HE; Klein, I; Pinedo, HM; van der Vijgh, WJ; Vermorken, JB	1
Andrews, PA; Howell, SB; Mann, SC; Velury, S	1
Chambers, JT; Chambers, SK; Kohorn, EI; Lawrence, R; Schwartz, PE	1
Andrews, PA; Howell, SB; Murphy, MP	1

Reviews

2 review(s) available for platinum and Carcinoma

Article	Year
Concurrent chemoradiotherapy comparison of taxanes and platinum versus 5-fluorouracil and platinum in nasopharyngeal carcinoma treatment. Chinese medical journal, 2014, Volume: 127, Issue:1 Topics: Carcinoma; Chemoradiotherapy; Fluorouracil; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Platinum; Taxoids; Treatment Outcome	2014
Efficacy and safety of topotecan in the treatment of advanced ovarian carcinoma. Seminars in oncology, 1997, Volume: 24, Issue:1 Suppl 5 Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Disease-Free Survival; Drug Administration Schedule; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Humans; Infusions, Intravenous; Multicenter Studies as Topic; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Platinum; Remission Induction; Safety; Survival Rate; Topoisomerase I Inhibitors; Topotecan	1997

Article

Year

Concurrent chemoradiotherapy comparison of taxanes and platinum versus 5-fluorouracil and platinum in nasopharyngeal carcinoma treatment.

Chinese medical journal, 2014, Volume: 127, Issue:1

Topics: Carcinoma; Chemoradiotherapy; Fluorouracil; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Platinum; Taxoids; Treatment Outcome

2014

Efficacy and safety of topotecan in the treatment of advanced ovarian carcinoma.

Seminars in oncology, 1997, Volume: 24, Issue:1 Suppl 5

Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Disease-Free Survival; Drug Administration Schedule; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Humans; Infusions, Intravenous; Multicenter Studies as Topic; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Platinum; Remission Induction; Safety; Survival Rate; Topoisomerase I Inhibitors; Topotecan

1997

Trials

5 trial(s) available for platinum and Carcinoma

Article	Year
Clinical and molecular characteristics of ARIEL3 patients who derived exceptional benefit from rucaparib maintenance treatment for high-grade ovarian carcinoma. Gynecologic oncology, 2022, Volume: 167, Issue:3 Topics: Antineoplastic Agents; Carcinoma; Carcinoma, Ovarian Epithelial; Female; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Platinum; Poly(ADP-ribose) Polymerase Inhibitors	2022
Determination of platinum in plasma of patients affected by inoperable lung carcinoma treated with radiotherapy and concurrent low-dose continuous infusion of cis-dichlorodiammine platinum(II). Cancer chemotherapy and pharmacology, 1995, Volume: 35, Issue:6 Topics: Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Computer Simulation; Humans; Infusions, Intravenous; Lung Neoplasms; Mass Spectrometry; Platinum	1995
Oral etoposide is active against platinum-resistant epithelial ovarian cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:1 Topics: Administration, Oral; Adult; Aged; Carcinoma; Drug Resistance; Etoposide; Female; Humans; Middle Aged; Ovarian Neoplasms; Platinum; Treatment Outcome	1994
Combination of oxaliplatin plus irinotecan in patients with gastrointestinal tumors: results of two independent phase I studies with pharmacokinetics. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma; Digestive System Neoplasms; Dose-Response Relationship, Drug; Female; Gilbert Disease; Glucuronates; Glucuronides; Humans; Irinotecan; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Platinum; Treatment Outcome	1999
Ifosfamide and mesna in previously treated advanced epithelial ovarian cancer: activity in platinum-resistant disease. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1992, Volume: 10, Issue:2 Topics: Acute Kidney Injury; Adult; Aged; Carcinoma; Drug Evaluation; Drug Resistance; Female; Humans; Ifosfamide; Mesna; Middle Aged; Ovarian Neoplasms; Platinum	1992

Other Studies

46 other study(ies) available for platinum and Carcinoma

Article	Year
Clinicopathological prognostic parameters in patients with tubo-ovarian carcinoma effusions. Cytopathology : official journal of the British Society for Clinical Cytology, 2022, Volume: 33, Issue:4 Topics: Biomarkers, Tumor; Carcinoma; Cystadenocarcinoma, Serous; Female; Humans; Ovarian Neoplasms; Platinum; Pleural Effusion, Malignant; Prognosis; Retrospective Studies	2022
Clinical efficacy and safety of pemetrexed with or without either Bevacizumab or Pembrolizumab in patients with metastatic nonsquamous non-small cell carcinoma. Asia-Pacific journal of clinical oncology, 2023, Volume: 19, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Humans; Lung Neoplasms; Pemetrexed; Platinum; Retrospective Studies; Treatment Outcome	2023
Genomic and epigenomic Science translational medicine, 2022, 07-06, Volume: 14, Issue:652 Topics: BRCA1 Protein; BRCA2 Protein; Carcinoma; Epigenomics; Female; Genomics; Humans; Mutation; Ovarian Neoplasms; Platinum; Triple Negative Breast Neoplasms	2022
Pro-apoptotic and size-reducing effects of protein corona-modulating nano-architectures enclosing platinum prodrug in Biomaterials science, 2022, Oct-25, Volume: 10, Issue:21 Topics: Antineoplastic Agents; Carcinoma; Caspase 3; Cell Line, Tumor; Humans; Nanoparticles; Peptides; Platinum; Prodrugs; Protein Corona; Transferrin; Vascular Endothelial Growth Factor A	2022
Case report: Durable response after pembrolizumab in combination with radiation - induced abscopal effect in platinum - refractory metastatic endometrial clear cell carcinoma. Frontiers in immunology, 2022, Volume: 13 Topics: Antibodies, Monoclonal, Humanized; Carcinoma; Female; Humans; Platinum; Uterine Neoplasms	2022
Metastatic lymphoepithelial carcinoma of the parotid gland: A case of prolonged response with platinum-gemcitabine regimen. Oral oncology, 2023, Volume: 138 Topics: Carcinoma; Gemcitabine; Humans; Parotid Gland; Parotid Neoplasms; Platinum	2023
Blocking xCT and PI3K/Akt pathway synergized with DNA damage of Riluzole-Pt(IV) prodrugs for cancer treatment. European journal of medicinal chemistry, 2023, Mar-15, Volume: 250 Topics: Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Cisplatin; DNA Damage; Humans; Phosphatidylinositol 3-Kinases; Platinum; Prodrugs; Proto-Oncogene Proteins c-akt; Riluzole	2023
Synthesis, Characterization and Biological Investigation of the Platinum(IV) Tolfenamato Prodrug-Resolving Cisplatin-Resistance in Ovarian Carcinoma Cell Lines. International journal of molecular sciences, 2023, Mar-16, Volume: 24, Issue:6 Topics: Antineoplastic Agents; Carcinoma; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cisplatin; Female; Humans; Ovarian Neoplasms; Platinum; Prodrugs	2023
BRCA gene amplification in primary peritoneal high-grade serous carcinoma patient with intrinsic resistance to platinum treatment: a case report. Pathologica, 2023, Volume: 115, Issue:2 Topics: BRCA1 Protein; BRCA2 Protein; Carcinoma; Female; Gene Amplification; Humans; Mutation; Ovarian Neoplasms; Platinum	2023
Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial. The Lancet. Oncology, 2020, Volume: 21, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Disease Progression; Double-Blind Method; Female; Humans; Indoles; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Platinum; Poly(ADP-ribose) Polymerase Inhibitors; Progression-Free Survival; Treatment Outcome	2020
Flavonoids Restore Platinum Drug Sensitivity to Ovarian Carcinoma Cells in a Phospho-ERK1/2-Dependent Fashion. International journal of molecular sciences, 2020, Sep-07, Volume: 21, Issue:18 Topics: 3T3-L1 Cells; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Flavonoids; Humans; MAP Kinase Signaling System; Mice; Ovarian Neoplasms; Paclitaxel; Platinum; Tumor Microenvironment	2020
Next generation platinum salt in nasopharygeal carcinoma. The Lancet. Oncology, 2021, Volume: 22, Issue:5 Topics: Carcinoma; Chemoradiotherapy; Cisplatin; Cyclobutanes; Fluorouracil; Humans; Induction Chemotherapy; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Organoplatinum Compounds; Platinum	2021
Claudin-4 Expression is Associated With Survival in Ovarian Cancer But Not With Chemotherapy Response. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists, 2018, Volume: 37, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; BRCA1 Protein; BRCA2 Protein; Carcinoma; Carcinoma, Ovarian Epithelial; Claudin-4; Cohort Studies; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; Prognosis; Sweden; Tissue Array Analysis	2018
Endoplasmic reticulum stress is involved in the response of human laryngeal carcinoma cells to Carboplatin but is absent in Carboplatin-resistant cells. PloS one, 2013, Volume: 8, Issue:9 Topics: Apoptosis; Blotting, Southwestern; Blotting, Western; Carboplatin; Carcinoma; Cell Line, Tumor; Cell Survival; Cinnamates; Cyclic N-Oxides; DNA Primers; Drug Resistance, Neoplasm; Endoplasmic Reticulum Stress; Gene Silencing; Humans; Laryngeal Neoplasms; Platinum; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Signal Transduction; Spin Labels; Thiourea	2013
Retrospective comparative study of irinotecan and pegylated liposomal doxorubicin for platinum-resistant or -refractory epithelial ovarian and primary peritoneal carcinoma. Archives of gynecology and obstetrics, 2014, Volume: 290, Issue:5 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma; Carcinoma, Ovarian Epithelial; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Irinotecan; Kaplan-Meier Estimate; Middle Aged; Neoplasms, Glandular and Epithelial; Neutropenia; Ovarian Neoplasms; Peritoneal Neoplasms; Platinum; Polyethylene Glycols; Retrospective Studies; Salvage Therapy; Treatment Outcome	2014
Magnesium protects against cisplatin-induced acute kidney injury without compromising cisplatin-mediated killing of an ovarian tumor xenograft in mice. American journal of physiology. Renal physiology, 2015, Jul-01, Volume: 309, Issue:1 Topics: Acute Kidney Injury; Animals; Antineoplastic Agents; Carcinoma; Cation Transport Proteins; Cell Line, Tumor; Cisplatin; Dietary Supplements; Female; Gene Expression; Humans; Kidney; Magnesium; Mice, Nude; Ovarian Neoplasms; Platinum; Xenograft Model Antitumor Assays	2015
Photoinduced cytotoxicity by a platinum diimine complex employing magnetite-silica nanocomposites as delivery vehicles. Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 2015, Volume: 28, Issue:5 Topics: Carcinoma; Cell Line, Tumor; Drug Delivery Systems; Dynamic Light Scattering; Ferrosoferric Oxide; Humans; Light; Microscopy, Electron, Transmission; Nanocomposites; Photosensitizing Agents; Platinum; Silicon Dioxide; Spectroscopy, Fourier Transform Infrared; Tartrates; X-Ray Diffraction	2015
[Efficacy and safety evaluation of gemcitabine combined with ifosfamide in patients with advanced nasopharyngeal carcinoma after failure of platinum-based chemotherapy]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2015, Volume: 37, Issue:8 Topics: Anemia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Deoxycytidine; Disease-Free Survival; Gemcitabine; Humans; Ifosfamide; Induction Chemotherapy; Kaplan-Meier Estimate; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neutropenia; Platinum; Remission Induction; Salvage Therapy; Survival Rate; Thrombocytopenia; Treatment Failure	2015
Efficacy and safety of Vinflunine for advanced or metastatic urothelial carcinoma in routine practice based on the French multi-centre CURVE study. BMC cancer, 2016, Mar-14, Volume: 16 Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Disease-Free Survival; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Platinum; Retrospective Studies; Urologic Neoplasms; Urothelium; Vinblastine	2016
Erythema elevatum diutinum as a paraneoplastic syndrome in a patient with pulmonary lymphoepithelioma-like carcinoma. Lung cancer (Amsterdam, Netherlands), 2009, Volume: 63, Issue:1 Topics: Antineoplastic Agents; Biopsy; Carcinoma; Erythema; Female; Humans; Lung; Lung Neoplasms; Middle Aged; Paraneoplastic Syndromes; Platinum; Remission Induction; Skin; Tomography, X-Ray Computed; Treatment Outcome	2009
Cellular uptake of platinum nanoparticles in human colon carcinoma cells and their impact on cellular redox systems and DNA integrity. Chemical research in toxicology, 2009, Volume: 22, Issue:4 Topics: Carcinoma; Cell Line, Tumor; Colonic Neoplasms; Comet Assay; DNA Damage; DNA-Formamidopyrimidine Glycosylase; Glutathione; Humans; Metal Nanoparticles; Microscopy, Electron, Transmission; Particle Size; Platinum; Reactive Oxygen Species	2009
Is the current concept of recurrent ovarian carcinoma as a chronic disease also applicable in platinum resistant patients? Archives of gynecology and obstetrics, 2010, Volume: 281, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; Carcinoma; Cohort Studies; Drug Resistance, Neoplasm; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Platinum; Retrospective Studies	2010
Evaluation of environmental contamination by platinum and exposure risks for healthcare workers during a heated intraperitoneal perioperative chemotherapy (HIPEC) procedure. Journal of surgical oncology, 2011, Jan-01, Volume: 103, Issue:1 Topics: Air Pollutants, Occupational; Antineoplastic Agents; Carcinoma; Combined Modality Therapy; Environmental Monitoring; Gloves, Surgical; Humans; Hyperthermia, Induced; Infusions, Parenteral; Inhalation Exposure; Medical Staff, Hospital; Occupational Exposure; Operating Rooms; Organoplatinum Compounds; Oxaliplatin; Peritoneal Neoplasms; Platinum	2011
Outcomes after multiple lines of chemotherapy for platinum-resistant epithelial cancers of the ovary, peritoneum, and fallopian tube. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2011, Volume: 21, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; CA-125 Antigen; Carcinoma; Carcinoma, Ovarian Epithelial; Cisplatin; Cytotoxins; Deoxycytidine; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fallopian Tube Neoplasms; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Platinum; Polyethylene Glycols; Prognosis; Proportional Hazards Models; Retrospective Studies; Survival Analysis; Taxoids; Treatment Outcome	2011
HERV-K hypomethylation in ovarian clear cell carcinoma is associated with a poor prognosis and platinum resistance. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2011, Volume: 21, Issue:1 Topics: Adult; Biomarkers; Carcinoma; DNA Methylation; Drug Resistance, Neoplasm; Endogenous Retroviruses; Female; Gene Expression; Humans; Kaplan-Meier Estimate; Long Interspersed Nucleotide Elements; Middle Aged; Ovarian Neoplasms; Platinum; Prognosis; Restriction Mapping; Survival Analysis	2011
Optimal therapeutic management of patients with distinct clinicopathological cancer of unknown primary subsets. Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23 Suppl 10 Topics: Adenocarcinoma; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Fluorouracil; Humans; Lymphatic Metastasis; Neoplasms, Unknown Primary; Platinum; Prognosis; Taxoids; Treatment Outcome	2012
Outcomes of induction chemotherapy followed by concurrent chemoradiation for nasopharyngeal carcinoma. Oral oncology, 2013, Volume: 49, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy; Chemotherapy, Adjuvant; Child; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Hydroxyurea; Induction Chemotherapy; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Platinum; Radiotherapy Dosage; Remission Induction; Survival Rate; Treatment Outcome; Young Adult	2013
Pegylated liposomal doxorubicin consolidation therapy after platinum/paclitaxel-based chemotherapy for suboptimally debulked, advanced-stage epithelial ovarian cancer patients. The oncologist, 2006, Volume: 11, Issue:4 Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Platinum; Polyethylene Glycols; Time Factors	2006
Enhancement of cisplatin sensitivity and platinum uptake by 40 degrees C hyperthermia in resistant cells. Cancer letters, 1997, Oct-28, Volume: 119, Issue:1 Topics: Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Humans; Hyperthermia, Induced; Maxillary Neoplasms; Platinum	1997
[The study of platinum concentration in retroperitoneal lymph nodes after intraperitoneal carboplatin in ovarian tumors]. Zhonghua fu chan ke za zhi, 1995, Volume: 30, Issue:5 Topics: Adult; Aged; Carboplatin; Carcinoma; Cystadenocarcinoma, Mucinous; Female; Humans; Infusions, Parenteral; Lymph Nodes; Middle Aged; Ovarian Neoplasms; Platinum; Retroperitoneal Space	1995
Chlorambucil for platinum-refractory ovarian cancer. Clinical oncology (Royal College of Radiologists (Great Britain)), 1994, Volume: 6, Issue:3 Topics: Adult; Aged; Carcinoma; Chlorambucil; Combined Modality Therapy; Drug Resistance; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Platinum; Remission Induction; Retrospective Studies; Survival Rate	1994
Protective effects of dithiocarbamates against toxicity of cis-diamminedichloroplatinum in mice. Biological & pharmaceutical bulletin, 1993, Volume: 16, Issue:4 Topics: Animals; Aspartate Aminotransferases; Blood Urea Nitrogen; Carcinoma; Chelating Agents; Cisplatin; Colonic Neoplasms; Diarrhea; Male; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Platinum; Thiocarbamates; Tissue Distribution	1993
Platinum-based chemotherapy of high-risk stage I epithelial ovarian cancer following comprehensive surgical staging. Obstetrics and gynecology, 1993, Volume: 82, Issue:1 Topics: Adolescent; Adult; Aged; Carcinoma; Cisplatin; Combined Modality Therapy; Female; Humans; Middle Aged; Ovarian Neoplasms; Platinum; Retrospective Studies; Survival Rate	1993
ras mutation and platinum resistance in human ovarian carcinomas in vitro. International journal of cancer, 1998, Jul-03, Volume: 77, Issue:1 Topics: Carcinoma; Drug Resistance, Neoplasm; Female; Genes, ras; Humans; Mutation; Ovarian Neoplasms; Platinum; Tumor Cells, Cultured	1998
Cytotoxicity, cellular uptake, and cellular biotransformations of oxaliplatin in human colon carcinoma cells. Oncology research, 1998, Volume: 10, Issue:11-12 Topics: Antineoplastic Agents; Biotransformation; Carcinoma; Colonic Neoplasms; DNA Adducts; Humans; Organoplatinum Compounds; Oxaliplatin; Platinum; Tumor Cells, Cultured	1998
Cellular pharmacology of cis and trans pairs of platinum complexes in cisplatin-sensitive and -resistant human ovarian carcinoma cells. Chemico-biological interactions, 1999, Nov-15, Volume: 123, Issue:1 Topics: Antineoplastic Agents; Apoptosis; Carcinoma; Cell Division; Cisplatin; DNA Adducts; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Growth Inhibitors; Humans; Organoplatinum Compounds; Ovarian Neoplasms; Platinum; Stereoisomerism; Tumor Cells, Cultured; Tumor Suppressor Protein p53	1999
The cellular basis of the efficacy of the trinuclear platinum complex BBR 3464 against cisplatin-resistant cells. Journal of inorganic biochemistry, 1999, Volume: 77, Issue:1-2 Topics: Adaptor Proteins, Signal Transducing; Adenosine Triphosphatases; Antineoplastic Agents; Base Pair Mismatch; Bone Neoplasms; Carcinoma; Carrier Proteins; Cisplatin; Colonic Neoplasms; Cross-Linking Reagents; DNA Polymerase beta; DNA Repair; DNA Repair Enzymes; DNA-Binding Proteins; DNA, Neoplasm; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Mismatch Repair Endonuclease PMS2; MutL Protein Homolog 1; MutS Homolog 2 Protein; Neoplasm Proteins; Nuclear Proteins; Organoplatinum Compounds; Osteosarcoma; Platinum; Proteins; Proto-Oncogene Proteins; Tumor Cells, Cultured	1999
Cell-surface-associated nucleic acid in tumorigenic cells made visible with platinum-pyrimidine complexes by electron microscopy. Proceedings of the National Academy of Sciences of the United States of America, 1975, Volume: 72, Issue:3 Topics: Animals; Carcinoma; Cattle; Cell Line; Cell Membrane; Cell Nucleolus; Chickens; Chromatin; Cricetinae; DNA; Fibroblasts; Humans; Leukemia L1210; Mice; Microscopy, Electron; Mouth Neoplasms; Platinum; Pyrimidines; Rats; Ribosomes; Sarcoma 180; Staining and Labeling; T-Lymphocytes	1975
The long-term retention of platinum in human tissues following the administration of cisplatin or carboplatin for cancer chemotherapy. European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A, Issue:8-9 Topics: Adolescent; Adult; Aged; Carboplatin; Carcinoma; Cisplatin; Erythrocytes; Female; Humans; Liver; Male; Middle Aged; Osteosarcoma; Ovarian Neoplasms; Platinum; Teratoma; Testicular Neoplasms; Time Factors	1992
Synergistic cytotoxic actions of cisplatin and liposomal valinomycin on human ovarian carcinoma cells. Cancer chemotherapy and pharmacology, 1991, Volume: 28, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cell Line; Cell Survival; Cisplatin; Drug Carriers; Drug Screening Assays, Antitumor; Drug Synergism; Female; Humans; Liposomes; Ovarian Neoplasms; Platinum; Tumor Cells, Cultured; Valinomycin	1991
Tissue platinum concentrations and cisplatin schedules. Lancet (London, England), 1990, Oct-20, Volume: 336, Issue:8721 Topics: Animals; Carcinoma; Cisplatin; Drug Administration Schedule; Female; Ganglia, Spinal; Injections, Intraperitoneal; Ovarian Neoplasms; Peripheral Nerves; Platinum; Rats	1990
Neoadjuvant chemotherapy in stage X ovarian carcinoma. Gynecologic oncology, 1990, Volume: 37, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Neoplasm Staging; Ovarian Neoplasms; Platinum; Survival Analysis	1990
Pharmacokinetics of carboplatin after i.v. administration. Cancer treatment reports, 1987, Volume: 71, Issue:12 Topics: Carboplatin; Carcinoma; Female; Humans; Injections, Intravenous; Organoplatinum Compounds; Ovarian Neoplasms; Platinum	1987
cis-Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells. Cancer research, 1988, Jan-01, Volume: 48, Issue:1 Topics: Carcinoma; Cell Membrane; Cisplatin; Dinitrophenols; Drug Resistance; Female; Humans; Ouabain; Ovarian Neoplasms; Platinum; Tumor Cells, Cultured	1988
Evaluation of the role of second-look surgery in ovarian cancer. Obstetrics and gynecology, 1988, Volume: 72, Issue:3 Pt 1 Topics: Adolescent; Adult; Aged; Carcinoma; Combined Modality Therapy; Evaluation Studies as Topic; False Negative Reactions; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Platinum; Prognosis; Regression Analysis; Reoperation; Retrospective Studies; Surgical Procedures, Operative; Time Factors	1988
Metallothionein-mediated cisplatin resistance in human ovarian carcinoma cells. Cancer chemotherapy and pharmacology, 1987, Volume: 19, Issue:2 Topics: Cadmium; Carcinoma; Cell Compartmentation; Cells, Cultured; Cisplatin; Drug Resistance; Female; Glutathione; Humans; Metallothionein; Ovarian Neoplasms; Platinum; Zinc	1987